journal
MENU ▼
Read by QxMD icon Read
search

Journal of the American College of Cardiology

journal
https://www.readbyqxmd.com/read/27914699/cangrelor-use-since-fda%C3%A2-approval-a-single-center-real-world-experience-at-a-tertiary-care-hospital
#1
LETTER
Muthiah Vaduganathan, Arman Qamar, Abhayjit Singh, Ramkumar V Venkateswaran, Paul M Szumita, Kevin J Croce, Laura Mauri, Jane A Leopold, Pinak B Shah, Piotr Sobieszczyk, David P Faxon, Deepak L Bhatt
No abstract text is available yet for this article.
November 23, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27908576/the-united-states-pediatric-cardiology-2015-workforce-assessment-a%C3%A2-survey%C3%A2-of-current-training-and%C3%A2-employment-patterns-a-report-of-the-american-college-of-cardiology-american-heart-association-american-academy-of-pediatrics-section-on-cardiology-and-cardiac
#2
Robert D Ross, Shubhika Srivastava, Antonio G Cabrera, Holly S Ruch-Ross, Carrie L Radabaugh, L LuAnn Minich, William T Mahle, David W Brown
No abstract text is available yet for this article.
November 21, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27856208/randomized-comparison-of-allogeneic-vs-autologous-mesenchymal-stem-cells-for-non-lschemic-dilated-cardiomyopathy-poseidon-dcm-trial
#3
Joshua M Hare, Darcy L DiFede, Angela M Castellanos, Victoria Florea, Ana M Landin, Jill El-Khorazaty, Aisha Khan, Muzammil Mushtaq, Maureen H Lowery, John J Byrnes, Robert C Hendel, Mauricio G Cohen, Carlos E Alfonso, Krystalenia Valasaki, Marietsy V Pujol, Samuel Golpanian, Eduard Ghersin, Joel E Fishman, Pradip Pattany, Samirah A Gomes, Cindy Delgado, Roberto Miki, Fouad Abuzeid, Mayra Vidro-Casiano, Courtney Premer, Audrey Medina, Valeria Porras, Konstantinos E Hatzistergos, Erica Anderson, Adam Mendizabal, Raul Mitrani, Alan W Heldman
BACKGROUND: While human mesenchymal stem cells (hMSCs) have been tested in ischemic cardiomyopathy, few studies exist in chronic non-ischemic dilated cardiomyopathy (NIDCM). OBJECTIVES: The POSEIDON-DCM trial is a randomized comparison of safety and efficacy of autologous (auto) vs. allogeneic (allo) bone marrow-derived hMSCs in NIDCM. METHODS: Thirty-seven patients were randomized to either allo- or auto-hMSCs in a 1:1 ratio. Patients were recruited between December 2011 and July 2015 at the University of Miami Hospital...
November 14, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27851992/2016-aha-acc-guideline-on-the-management-of-patients-with-lower-extremity-peripheral-artery-disease-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-practice-guidelines
#4
Marie D Gerhard-Herman, Heather L Gornik, Coletta Barrett, Neal R Barshes, Matthew A Corriere, Douglas E Drachman, Lee A Fleisher, Francis Gerry R Fowkes, Naomi M Hamburg, Scott Kinlay, Robert Lookstein, Sanjay Misra, Leila Mureebe, Jeffrey W Olin, Rajan A G Patel, Judith G Regensteiner, Andres Schanzer, Mehdi H Shishehbor, Kerry J Stewart, Diane Treat-Jacobson, M Eileen Walsh
No abstract text is available yet for this article.
November 8, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27851991/2016-aha-acc-guideline-on-the-management-of-patients-with-lower-extremity-peripheral-artery-disease-executive-summary-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-practice-guidelines
#5
Marie D Gerhard-Herman, Heather L Gornik, Coletta Barrett, Neal R Barshes, Matthew A Corriere, Douglas E Drachman, Lee A Fleisher, Francis Gerry R Fowkes, Naomi M Hamburg, Scott Kinlay, Robert Lookstein, Sanjay Misra, Leila Mureebe, Jeffrey W Olin, Rajan A G Patel, Judith G Regensteiner, Andres Schanzer, Mehdi H Shishehbor, Kerry J Stewart, Diane Treat-Jacobson, M Eileen Walsh
No abstract text is available yet for this article.
November 8, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27825770/estimating-longitudinal-risks-and-benefits-from-cardiovascular-preventive-therapies-among-medicare-patients-the-million-hearts-longitudinal-ascvd-risk-assessment-tool
#6
Donald M Lloyd-Jones, Mark D Huffman, Kunal N Karmali, Darshak M Sanghavi, Janet S Wright, Colleen Pelser, Martha Gulati, Frederick A Masoudi, David C Goff
The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiology support the program. The Cardiovascular Risk Reduction Model was developed by Million Hearts and the Center for Medicare & Medicaid Services as a strategy to asses a value-based payment approach toward reduction in 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) by implementing cardiovascular preventive strategies to manage the "ABCS" (aspirin therapy in appropriate patients, blood pressure control, cholesterol management, and smoking cessation)...
October 28, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27815102/cerebral-embolic-protection-during-transcatheter-aortic-valve-replacement-a-disconnect-between-logic-and-data
#7
EDITORIAL
Azeem Latib, Matteo Pagnesi
No abstract text is available yet for this article.
October 28, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27816552/post-fda-approval-initial-us-clinical-experience-with-watchman-left-atrial-appendage-closure-for-stroke-prevention-in-atrial-fibrillation
#8
Vivek Y Reddy, Douglas N Gibson, Saibal Kar, William O'Neill, Shephal K Doshi, Rodney P Horton, Maurice Buchbinder, Nicole T Gordon, David R Holmes
BACKGROUND: Left atrial appendage closure (LAAC) using the Watchman device was FDA-approved as a stroke prevention alternative to warfarin for patients with non-valvular atrial fibrillation. However, clinical decision-making is confounded by the fact that while LAAC avoids the anticoagulant-related lifetime risk of bleeding, implantation is associated with up-front complications. Thus, enthusiasm for LAAC as a treatment option has been appropriately tempered, particularly as the therapy is introduced beyond the clinical trial sites into general clinical practice...
October 27, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27815103/acc-and-aha-setting-a-new-standard-for-hospital-accreditation-%C3%A2-together
#9
EDITORIAL
Richard A Chazal, Steven Houser
No abstract text is available yet for this article.
October 27, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27815101/cerebral-embolic-protection-during-transcatheter-aortic-valve-replacement
#10
Samir R Kapadia, Susheel Kodali, Raj Makkar, Roxana Mehran, Ronald M Lazar, Robert Zivadinov, Michael G Dwyer, Hasan Jilaihawi, Renu Virmani, Saif Anwaruddin, Vinod H Thourani, Tamim Nazif, Norman Mangner, Felix Woitek, Amar Krishnaswamy, Stephanie Mick, Tarun Chakravarty, Mamoo Nakamura, James M McCabe, Lowell Satler, Alan Zajarias, Wilson Y Szeto, Lars Svensson, Maria C Alu, Roseann M White, Carlye Kraemer, Azin Parhizgar, Martin B Leon, Axel Linke
BACKGROUND: Neurological events and brain infarction after transcatheter aortic valve replacement (TAVR) are concerns which may be reduced with transcatheter embolic protection (TEP). OBJECTIVE: Evaluate the safety and efficacy of TEP during TAVR. METHODS: Nineteen centers randomized 363 patients undergoing TAVR to safety (n=123), device imaging (n=121), and control imaging (n=119). The primary safety endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 30 days and the primary efficacy endpoint was reduction in new lesion volume in protected brain territories on MRI scans at 2-7 days...
October 27, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27810349/mechanical-support-for-cardiogenic-shock-lost-in-translation
#11
EDITORIAL
Uwe Zeymer, Holger Thiele
No abstract text is available yet for this article.
October 27, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27810348/impella-versus-intra-aortic-balloon-pump-for-treatment-of-cardiogenic-shock-a-meta-analysis-of-randomized-controlled-trials
#12
LETTER
Dagmar M Ouweneel, Erlend Eriksen, Melchior Seyfarth, José P S Henriques
No abstract text is available yet for this article.
October 27, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27810347/impella-cp-versus-intra-aortic-balloon-pump-in-acute-myocardial-infarction-complicated-by-cardiogenic-shock-the-impress-trial
#13
Dagmar M Ouweneel, Erlend Eriksen, Krischan D Sjauw, Ivo M van Dongen, Alexander Hirsch, Erik J S Packer, M Marije Vis, Joanna J Wykrzykowska, Karel T Koch, Jan Baan, Robbert J de Winter, Jan J Piek, Wim K Lagrand, Bas A J M de Mol, Jan G P Tijssen, José P S Henriques
BACKGROUND: Despite advances in treatment, mortality in acute myocardial infarction complicated by cardiogenic shock remains high. Short-term mechanical circulatory support devices acutely improve hemodynamic conditions. The Impella CP is a new percutaneous circulatory support device that provides more hemodynamic support than the intra-aortic balloon pump (IABP). OBJECTIVES: The aim of this study was to determine whether the Impella CP can decrease 30-day mortality when compared with IABP in patients with severe shock complicating acute myocardial infarction...
October 27, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27793511/cultural-third-world-war-how-economic-disparity-adversely%C3%A2-affects%C3%A2-health
#14
EDITORIAL
Valentin Fuster
No abstract text is available yet for this article.
October 26, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27816551/assessing-the-safety-of-early-u-s-commercial-application-of-left-atrial-appendage-closure
#15
EDITORIAL
Jacqueline Saw, Matthew J Price
No abstract text is available yet for this article.
October 19, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27806919/two-year-outcomes-of-high-bleeding-risk-patients-after-polymer-free-drug-coated-stents
#16
Philippe Garot, Marie-Claude Morice, Damras Tresukosol, Stuart J Pocock, Ian T Meredith, Alexandre Abizaid, Didier Carrié, Christoph Naber, Andres Iñiguez, Suneel Talwar, Ian B A Menown, Evald H Christiansen, John Gregson, Samuel Copt, Thomas Hovasse, Philipp Lurz, Luc Maillard, Florian Krackhardt, Paul Ong, Jonathan Byrne, Simon Redwood, Ute Windhövel, Samantha Greene, Hans-Peter Stoll, Philip Urban
BACKGROUND: For patients at high risk for bleeding, a polymer-free metallic stent coated with biolimus-A9 followed by one-month dual antiplatelet therapy was safer and more effective than a bare metal stent at one year. OBJECTIVES: Longer-term follow-up is needed to determine whether these benefits are maintained. METHODS: In a prospective, multi-center, double blind trial, we randomly assigned 2466 high bleeding risk patients to receive a drug coated stent (DCS) or a bare metal stent (BMS) followed by one month dual antiplatelet therapy and 98...
October 14, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27692728/serial-changes-in-cognitive-function-following-transcatheter-aortic-valve-replacement
#17
Vincent Auffret, Francisco Campelo-Parada, Ander Regueiro, María Del Trigo, Olivier Chiche, Chekrallah Chamandi, Ricardo Allende, Juan G Cordoba-Soriano, Jean-Michel Paradis, Robert De Larochellière, Daniel Doyle, Eric Dumont, Siamak Mohammadi, Mélanie Côté, Alier Marrero, Rishi Puri, Josep Rodés-Cabau
BACKGROUND: Data regarding the mid- to long-term cognitive trajectory of transcatheter aortic valve (TAVR) recipients are scarce. OBJECTIVES: Changes in global cognition and specific cognitive domains up to 1 year post-TAVR were evaluated. METHODS: Fifty-one patients (median age 80.0 [interquartile range: 72.0 to 85.0] years; 37% women) underwent TAVR and prospective assessment of cognitive function using the Montreal Cognitive Assessment (MoCA) at baseline, short-term (30 days), and 1 year post-TAVR...
September 22, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27692727/can-tavr-make-me-smarter
#18
Philippe Généreux
No abstract text is available yet for this article.
September 22, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27692726/critical-limb-ischemia-an-expert-statement
#19
Mehdi H Shishehbor, Christopher J White, Bruce H Gray, Matthew T Menard, Robert Lookstein, Kenneth Rosenfield, Michael R Jaff
Critical limb ischemia (CLI), the most advanced form of peripheral artery disease, is associated with significant morbidity, mortality, and health care resource utilization. It is also associated with physical, as well as psychosocial, consequences such as amputation and depression. Importantly, after a major amputation, patients are at heightened risk of amputation on the contralateral leg. However, despite the technological advances to manage CLI with minimally invasive technologies, this condition often remains untreated, with significant disparities in revascularization and amputation rates according to race, socioeconomic status, and geographic region...
September 22, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27654853/tolvaptan-in-acute-heart-failure-time-to-move-on
#20
Randall C Starling, James B Young
No abstract text is available yet for this article.
September 15, 2016: Journal of the American College of Cardiology
journal
journal
20134
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"